Research over the past decade has revealed multiple potential mechanisms by which dendritic cells contribute to the immunopathogenesis of systemic lupus erythematosus. Genetic abnormalities in ...

Systemic lupus erythematosus (SLE ... coupled with a better understanding of SLE pathogenesis, have renewed interest in this disease area. Product candidates are in development for different ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...

MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity. There is a growing body of literature implicating a role for dendritic cells (DCs) in many of the disease ...

“In addition to decreasing the inflammation by decreasing lesional staphylococcus aureus, the mupirocin treatment also lowered skin monocyte levels, which are important in driving cutaneous lupus,” ...